VUSE was a perennial underperformer, but a January 2023 strategy change provides new hope for shareholders of this all-cap fund with a 0.50% expense ratio. VUSE's current fundamentals are solid ...
When the Food and Drug Administration barred the sale of a brand of menthol e-cigarettes that officials said were a factor in ...
British American Tobacco operates as the world's second-largest tobacco company by volume, though global cigarette ...
British American Tobacco Malaysia is impacted by new e-cigarette laws. See why BATMF stock remains a Hold despite challenges in the vapor market.
Launched on 01/22/2014, the Vident U.S. Equity Strategy ETF (VUSE) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Value category of the market. Market cap ...
The U.S. Supreme Court appeared skeptical Tuesday of the government's attempt to limit the number of Food and Drug ...
The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...
Despite persistent regulatory uncertainty and declining cigarette usage worldwide, the tobacco industry is alive and well in ...
"We neither like nor dislike the Fifth Circuit," Suri replied. "What we dislike is for the other side to be able to choose ...
In the final days of President Joe Biden’s term, the US Food and Drug Administration (FDA) has placed a proposal that could ...
It authorised the marketing of three products from RJ Reynolds, under the Vuse brand. The FDA decided that the benefit to adults trying to quit smoking outweighs the risk of teenagers becoming hooked.